SAK: MODULATION OF CELLULAR PROLIFERATION FOR TREATMENT OF CANCER

Details for Australian Patent Application No. 2002318934 (hide)

Owner RIGEL PHARMACEUTICALS, INC.

Inventors DEMO, Susan; HITOSHI, Yasumichi; JENKINS, Yonchu

Pub. Number AU-A-2002318934

PCT Number PCT/US02/24312

PCT Pub. Number WO2003/012055

Priority 60/309,632 01.08.01 US; 10/026,021 21.12.01 US

Filing date 31 July 2002

Wipo publication date 17 February 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/309,632 01.08.01 US; 10/026,021 21.12.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002318934

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318935-METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISTAL BOWEL LESIONS

2002318933-ANTISENSE MODULATION OF DUAL SPECIFIC PHOSPHATASE 9 EXPRESSION